Early stage biotechs are a #$%$-shoot.
Buy late stage or approved.
Your defense of Sunil is that he didn't agree to the reduced royalties recently, that he agreed to it a year ago?
Is that it?
Put words in his mouth and make up BS.
There are "rumors" that the pharma unit is up for sale.
Even if it really is, does all development at the unit come to a halt?
And why did they license Atrigel and file a patent application for it, if they have no plans to develop it?
More important, why would Sunil modify the agreement with Braeburn to REDUCE the Pruphin royalty upon the occurrence of any competition?
Why don't you write another pump piece for SA and then sell you remaining shares soon thereafter?
A sound alternative .... I like the low market cap and that it hasn't run yet.
PARTNERSHIP!!!!!!!!!!!!!!!!!!!! Idiots pumping nonsense!